Index by author
August 01, 2003; Volume 31,Issue 8
B
Bader, Augustinus
- You have accessCOMPARISON OF PRIMARY HUMAN HEPATOCYTES AND HEPATOMA CELL LINE HEPG2 WITH REGARD TO THEIR BIOTRANSFORMATION PROPERTIESStefan Wilkening, Frank Stahl and Augustinus BaderDrug Metabolism and Disposition August 2003, 31 (8) 1035-1042; DOI: https://doi.org/10.1124/dmd.31.8.1035
Bahr, Ute
- You have accessDEGRADATION OF GINSENOSIDES IN HUMANS AFTER ORAL ADMINISTRATIONMona Abdel Tawab, Ute Bahr, Michael Karas, Mario Wurglics and Manfred Schubert-ZsilaveczDrug Metabolism and Disposition August 2003, 31 (8) 1065-1071; DOI: https://doi.org/10.1124/dmd.31.8.1065
Burchell, Brian
- You have accessGLUCURONIDATION OF HMR1098 IN HUMAN MICROSOMES: EVIDENCE FOR THE INVOLVEMENT OF UGT1A1 IN THE FORMATION OF S-GLUCURONIDESBrian T. Ethell, Jens Riedel, Heinrich Englert, Herbert Jantz, Raymond Oekonomopulos and Brian BurchellDrug Metabolism and Disposition August 2003, 31 (8) 1027-1034; DOI: https://doi.org/10.1124/dmd.31.8.1027
C
Chen, Kevin
- You have accessA TRANSGENIC MOUSE MODEL WITH A LUCIFERASE REPORTER FOR STUDYING IN VIVO TRANSCRIPTIONAL REGULATION OF THE HUMAN CYP3A4 GENEWeisheng Zhang, Anthony F. Purchio, Kevin Chen, Jianming Wu, Li Lu, Richard Coffee, Pamela R. Contag and David B. WestDrug Metabolism and Disposition August 2003, 31 (8) 1054-1064; DOI: https://doi.org/10.1124/dmd.31.8.1054
Coffee, Richard
- You have accessA TRANSGENIC MOUSE MODEL WITH A LUCIFERASE REPORTER FOR STUDYING IN VIVO TRANSCRIPTIONAL REGULATION OF THE HUMAN CYP3A4 GENEWeisheng Zhang, Anthony F. Purchio, Kevin Chen, Jianming Wu, Li Lu, Richard Coffee, Pamela R. Contag and David B. WestDrug Metabolism and Disposition August 2003, 31 (8) 1054-1064; DOI: https://doi.org/10.1124/dmd.31.8.1054
Cohen, Lawrence H.
- You have accessIN VITRO DRUG INTERACTIONS OF CYTOCHROME P450: AN EVALUATION OF FLUOROGENIC TO CONVENTIONAL SUBSTRATESLawrence H. Cohen, Michael J. Remley, David Raunig and Alfin D. N. VazDrug Metabolism and Disposition August 2003, 31 (8) 1005-1015; DOI: https://doi.org/10.1124/dmd.31.8.1005
Cole, Susan P. C.
- You have accessMOLECULAR CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF RAT MULTIDRUG RESISTANCE PROTEIN 1 (MRP1)Kenichi Nunoya, Caroline E. Grant, Dawei Zhang, Susan P. C. Cole and Roger G. DeeleyDrug Metabolism and Disposition August 2003, 31 (8) 1016-1026; DOI: https://doi.org/10.1124/dmd.31.8.1016
Contag, Pamela R.
- You have accessA TRANSGENIC MOUSE MODEL WITH A LUCIFERASE REPORTER FOR STUDYING IN VIVO TRANSCRIPTIONAL REGULATION OF THE HUMAN CYP3A4 GENEWeisheng Zhang, Anthony F. Purchio, Kevin Chen, Jianming Wu, Li Lu, Richard Coffee, Pamela R. Contag and David B. WestDrug Metabolism and Disposition August 2003, 31 (8) 1054-1064; DOI: https://doi.org/10.1124/dmd.31.8.1054
Cui, Xiangmin
- You have accessIDENTIFICATION OF A RARE SULFONIC ACID METABOLITE OF ANDROGRAPHOLIDE IN RATSXiangjiu He, Jiankuan Li, Hao Gao, Feng Qiu, Ke Hu, Xiangmin Cui and Xinsheng YaoDrug Metabolism and Disposition August 2003, 31 (8) 983-985; DOI: https://doi.org/10.1124/dmd.31.8.983
D
Daidoji, Tomo
- You have accessGLUCURONIDATION AND EXCRETION OF NONYLPHENOL IN PERFUSED RAT LIVERTomo Daidoji, Hiroki Inoue, Seiyu Kato and Hiroshi YokotaDrug Metabolism and Disposition August 2003, 31 (8) 993-998; DOI: https://doi.org/10.1124/dmd.31.8.993
Deeley, Roger G.
- You have accessMOLECULAR CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF RAT MULTIDRUG RESISTANCE PROTEIN 1 (MRP1)Kenichi Nunoya, Caroline E. Grant, Dawei Zhang, Susan P. C. Cole and Roger G. DeeleyDrug Metabolism and Disposition August 2003, 31 (8) 1016-1026; DOI: https://doi.org/10.1124/dmd.31.8.1016
E
Elfarra, Adnan A.
- You have accessDETECTION OF CARBOXYLIC ACIDS AND INHIBITION OF HIPPURIC ACID FORMATION IN RATS TREATED WITH 3-BUTENE-1,2-DIOL, A MAJOR METABOLITE OF 1,3-BUTADIENEChristopher L. Sprague and Adnan A. ElfarraDrug Metabolism and Disposition August 2003, 31 (8) 986-992; DOI: https://doi.org/10.1124/dmd.31.8.986
Englert, Heinrich
- You have accessGLUCURONIDATION OF HMR1098 IN HUMAN MICROSOMES: EVIDENCE FOR THE INVOLVEMENT OF UGT1A1 IN THE FORMATION OF S-GLUCURONIDESBrian T. Ethell, Jens Riedel, Heinrich Englert, Herbert Jantz, Raymond Oekonomopulos and Brian BurchellDrug Metabolism and Disposition August 2003, 31 (8) 1027-1034; DOI: https://doi.org/10.1124/dmd.31.8.1027
Ethell, Brian T.
- You have accessGLUCURONIDATION OF HMR1098 IN HUMAN MICROSOMES: EVIDENCE FOR THE INVOLVEMENT OF UGT1A1 IN THE FORMATION OF S-GLUCURONIDESBrian T. Ethell, Jens Riedel, Heinrich Englert, Herbert Jantz, Raymond Oekonomopulos and Brian BurchellDrug Metabolism and Disposition August 2003, 31 (8) 1027-1034; DOI: https://doi.org/10.1124/dmd.31.8.1027
G
Gao, Hao
- You have accessIDENTIFICATION OF A RARE SULFONIC ACID METABOLITE OF ANDROGRAPHOLIDE IN RATSXiangjiu He, Jiankuan Li, Hao Gao, Feng Qiu, Ke Hu, Xiangmin Cui and Xinsheng YaoDrug Metabolism and Disposition August 2003, 31 (8) 983-985; DOI: https://doi.org/10.1124/dmd.31.8.983
Grant, Caroline E.
- You have accessMOLECULAR CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF RAT MULTIDRUG RESISTANCE PROTEIN 1 (MRP1)Kenichi Nunoya, Caroline E. Grant, Dawei Zhang, Susan P. C. Cole and Roger G. DeeleyDrug Metabolism and Disposition August 2003, 31 (8) 1016-1026; DOI: https://doi.org/10.1124/dmd.31.8.1016
H
He, Xiangjiu
- You have accessIDENTIFICATION OF A RARE SULFONIC ACID METABOLITE OF ANDROGRAPHOLIDE IN RATSXiangjiu He, Jiankuan Li, Hao Gao, Feng Qiu, Ke Hu, Xiangmin Cui and Xinsheng YaoDrug Metabolism and Disposition August 2003, 31 (8) 983-985; DOI: https://doi.org/10.1124/dmd.31.8.983
Hu, Ke
- You have accessIDENTIFICATION OF A RARE SULFONIC ACID METABOLITE OF ANDROGRAPHOLIDE IN RATSXiangjiu He, Jiankuan Li, Hao Gao, Feng Qiu, Ke Hu, Xiangmin Cui and Xinsheng YaoDrug Metabolism and Disposition August 2003, 31 (8) 983-985; DOI: https://doi.org/10.1124/dmd.31.8.983
I
Inoue, Hiroki
- You have accessGLUCURONIDATION AND EXCRETION OF NONYLPHENOL IN PERFUSED RAT LIVERTomo Daidoji, Hiroki Inoue, Seiyu Kato and Hiroshi YokotaDrug Metabolism and Disposition August 2003, 31 (8) 993-998; DOI: https://doi.org/10.1124/dmd.31.8.993
J
Jantz, Herbert
- You have accessGLUCURONIDATION OF HMR1098 IN HUMAN MICROSOMES: EVIDENCE FOR THE INVOLVEMENT OF UGT1A1 IN THE FORMATION OF S-GLUCURONIDESBrian T. Ethell, Jens Riedel, Heinrich Englert, Herbert Jantz, Raymond Oekonomopulos and Brian BurchellDrug Metabolism and Disposition August 2003, 31 (8) 1027-1034; DOI: https://doi.org/10.1124/dmd.31.8.1027
K
Kanamaru, Hiroshi
- You have accessDISPOSITION AND METABOLISM OF F6-1α,25(OH)2 VITAMIN D3 AND 1α,25(OH)2 VITAMIN D3 IN THE PARATHYROID GLANDS OF RATS DOSED WITH TRITIUM-LABELED COMPOUNDSSetsuko Komuro, Masayuki Sato and Hiroshi KanamaruDrug Metabolism and Disposition August 2003, 31 (8) 973-978; DOI: https://doi.org/10.1124/dmd.31.8.973
Karas, Michael
- You have accessDEGRADATION OF GINSENOSIDES IN HUMANS AFTER ORAL ADMINISTRATIONMona Abdel Tawab, Ute Bahr, Michael Karas, Mario Wurglics and Manfred Schubert-ZsilaveczDrug Metabolism and Disposition August 2003, 31 (8) 1065-1071; DOI: https://doi.org/10.1124/dmd.31.8.1065
Kato, Seiyu
- You have accessGLUCURONIDATION AND EXCRETION OF NONYLPHENOL IN PERFUSED RAT LIVERTomo Daidoji, Hiroki Inoue, Seiyu Kato and Hiroshi YokotaDrug Metabolism and Disposition August 2003, 31 (8) 993-998; DOI: https://doi.org/10.1124/dmd.31.8.993
Komuro, Setsuko
- You have accessDISPOSITION AND METABOLISM OF F6-1α,25(OH)2 VITAMIN D3 AND 1α,25(OH)2 VITAMIN D3 IN THE PARATHYROID GLANDS OF RATS DOSED WITH TRITIUM-LABELED COMPOUNDSSetsuko Komuro, Masayuki Sato and Hiroshi KanamaruDrug Metabolism and Disposition August 2003, 31 (8) 973-978; DOI: https://doi.org/10.1124/dmd.31.8.973
Kraemer, Thomas
- You have accessIDENTIFICATION OF CYTOCHROME P450 ENZYMES INVOLVED IN THE METABOLISM OF 4′-METHYL-α-PYRROLIDINOPROPIOPHENONE, A NOVEL SCHEDULED DESIGNER DRUG, IN HUMAN LIVER MICROSOMESDietmar Springer, Liane D. Paul, Roland F. Staack, Thomas Kraemer and Hans H. MaurerDrug Metabolism and Disposition August 2003, 31 (8) 979-982; DOI: https://doi.org/10.1124/dmd.31.8.979
Kunze, Kent L.
- You have accessKIIV, AN IN VIVO PARAMETER FOR PREDICTING THE MAGNITUDE OF A DRUG INTERACTION ARISING FROM COMPETITIVE ENZYME INHIBITIONJohn M. Neal, Kent L. Kunze, René H. Levy, Robert A. O'Reilly and William F. TragerDrug Metabolism and Disposition August 2003, 31 (8) 1043-1048; DOI: https://doi.org/10.1124/dmd.31.8.1043
L
Levy, René H.
- You have accessKIIV, AN IN VIVO PARAMETER FOR PREDICTING THE MAGNITUDE OF A DRUG INTERACTION ARISING FROM COMPETITIVE ENZYME INHIBITIONJohn M. Neal, Kent L. Kunze, René H. Levy, Robert A. O'Reilly and William F. TragerDrug Metabolism and Disposition August 2003, 31 (8) 1043-1048; DOI: https://doi.org/10.1124/dmd.31.8.1043
Li, Jiankuan
- You have accessIDENTIFICATION OF A RARE SULFONIC ACID METABOLITE OF ANDROGRAPHOLIDE IN RATSXiangjiu He, Jiankuan Li, Hao Gao, Feng Qiu, Ke Hu, Xiangmin Cui and Xinsheng YaoDrug Metabolism and Disposition August 2003, 31 (8) 983-985; DOI: https://doi.org/10.1124/dmd.31.8.983
Lu, Li
- You have accessA TRANSGENIC MOUSE MODEL WITH A LUCIFERASE REPORTER FOR STUDYING IN VIVO TRANSCRIPTIONAL REGULATION OF THE HUMAN CYP3A4 GENEWeisheng Zhang, Anthony F. Purchio, Kevin Chen, Jianming Wu, Li Lu, Richard Coffee, Pamela R. Contag and David B. WestDrug Metabolism and Disposition August 2003, 31 (8) 1054-1064; DOI: https://doi.org/10.1124/dmd.31.8.1054
M
Maurer, Hans H.
- You have accessIDENTIFICATION OF CYTOCHROME P450 ENZYMES INVOLVED IN THE METABOLISM OF 4′-METHYL-α-PYRROLIDINOPROPIOPHENONE, A NOVEL SCHEDULED DESIGNER DRUG, IN HUMAN LIVER MICROSOMESDietmar Springer, Liane D. Paul, Roland F. Staack, Thomas Kraemer and Hans H. MaurerDrug Metabolism and Disposition August 2003, 31 (8) 979-982; DOI: https://doi.org/10.1124/dmd.31.8.979
Miyazawa, Mitsuo
- You have accessROLES OF HUMAN CYP2A6 AND 2B6 AND RAT CYP2C11 AND 2B1 IN THE 10-HYDROXYLATION OF (–)-VERBENONE BY LIVER MICROSOMESMitsuo Miyazawa, Atsushi Sugie and Tsutomu ShimadaDrug Metabolism and Disposition August 2003, 31 (8) 1049-1053; DOI: https://doi.org/10.1124/dmd.31.8.1049
N
Neal, John M.
- You have accessKIIV, AN IN VIVO PARAMETER FOR PREDICTING THE MAGNITUDE OF A DRUG INTERACTION ARISING FROM COMPETITIVE ENZYME INHIBITIONJohn M. Neal, Kent L. Kunze, René H. Levy, Robert A. O'Reilly and William F. TragerDrug Metabolism and Disposition August 2003, 31 (8) 1043-1048; DOI: https://doi.org/10.1124/dmd.31.8.1043
Nunoya, Kenichi
- You have accessMOLECULAR CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF RAT MULTIDRUG RESISTANCE PROTEIN 1 (MRP1)Kenichi Nunoya, Caroline E. Grant, Dawei Zhang, Susan P. C. Cole and Roger G. DeeleyDrug Metabolism and Disposition August 2003, 31 (8) 1016-1026; DOI: https://doi.org/10.1124/dmd.31.8.1016
O
O'Reilly, Robert A.
- You have accessKIIV, AN IN VIVO PARAMETER FOR PREDICTING THE MAGNITUDE OF A DRUG INTERACTION ARISING FROM COMPETITIVE ENZYME INHIBITIONJohn M. Neal, Kent L. Kunze, René H. Levy, Robert A. O'Reilly and William F. TragerDrug Metabolism and Disposition August 2003, 31 (8) 1043-1048; DOI: https://doi.org/10.1124/dmd.31.8.1043
Oekonomopulos, Raymond
- You have accessGLUCURONIDATION OF HMR1098 IN HUMAN MICROSOMES: EVIDENCE FOR THE INVOLVEMENT OF UGT1A1 IN THE FORMATION OF S-GLUCURONIDESBrian T. Ethell, Jens Riedel, Heinrich Englert, Herbert Jantz, Raymond Oekonomopulos and Brian BurchellDrug Metabolism and Disposition August 2003, 31 (8) 1027-1034; DOI: https://doi.org/10.1124/dmd.31.8.1027
P
Paul, Liane D.
- You have accessIDENTIFICATION OF CYTOCHROME P450 ENZYMES INVOLVED IN THE METABOLISM OF 4′-METHYL-α-PYRROLIDINOPROPIOPHENONE, A NOVEL SCHEDULED DESIGNER DRUG, IN HUMAN LIVER MICROSOMESDietmar Springer, Liane D. Paul, Roland F. Staack, Thomas Kraemer and Hans H. MaurerDrug Metabolism and Disposition August 2003, 31 (8) 979-982; DOI: https://doi.org/10.1124/dmd.31.8.979
Purchio, Anthony F.
- You have accessA TRANSGENIC MOUSE MODEL WITH A LUCIFERASE REPORTER FOR STUDYING IN VIVO TRANSCRIPTIONAL REGULATION OF THE HUMAN CYP3A4 GENEWeisheng Zhang, Anthony F. Purchio, Kevin Chen, Jianming Wu, Li Lu, Richard Coffee, Pamela R. Contag and David B. WestDrug Metabolism and Disposition August 2003, 31 (8) 1054-1064; DOI: https://doi.org/10.1124/dmd.31.8.1054
Q
Qiu, Feng
- You have accessIDENTIFICATION OF A RARE SULFONIC ACID METABOLITE OF ANDROGRAPHOLIDE IN RATSXiangjiu He, Jiankuan Li, Hao Gao, Feng Qiu, Ke Hu, Xiangmin Cui and Xinsheng YaoDrug Metabolism and Disposition August 2003, 31 (8) 983-985; DOI: https://doi.org/10.1124/dmd.31.8.983
R
Raunig, David
- You have accessIN VITRO DRUG INTERACTIONS OF CYTOCHROME P450: AN EVALUATION OF FLUOROGENIC TO CONVENTIONAL SUBSTRATESLawrence H. Cohen, Michael J. Remley, David Raunig and Alfin D. N. VazDrug Metabolism and Disposition August 2003, 31 (8) 1005-1015; DOI: https://doi.org/10.1124/dmd.31.8.1005
Remley, Michael J.
- You have accessIN VITRO DRUG INTERACTIONS OF CYTOCHROME P450: AN EVALUATION OF FLUOROGENIC TO CONVENTIONAL SUBSTRATESLawrence H. Cohen, Michael J. Remley, David Raunig and Alfin D. N. VazDrug Metabolism and Disposition August 2003, 31 (8) 1005-1015; DOI: https://doi.org/10.1124/dmd.31.8.1005
Riedel, Jens
- You have accessGLUCURONIDATION OF HMR1098 IN HUMAN MICROSOMES: EVIDENCE FOR THE INVOLVEMENT OF UGT1A1 IN THE FORMATION OF S-GLUCURONIDESBrian T. Ethell, Jens Riedel, Heinrich Englert, Herbert Jantz, Raymond Oekonomopulos and Brian BurchellDrug Metabolism and Disposition August 2003, 31 (8) 1027-1034; DOI: https://doi.org/10.1124/dmd.31.8.1027
S
Sato, Masayuki
- You have accessDISPOSITION AND METABOLISM OF F6-1α,25(OH)2 VITAMIN D3 AND 1α,25(OH)2 VITAMIN D3 IN THE PARATHYROID GLANDS OF RATS DOSED WITH TRITIUM-LABELED COMPOUNDSSetsuko Komuro, Masayuki Sato and Hiroshi KanamaruDrug Metabolism and Disposition August 2003, 31 (8) 973-978; DOI: https://doi.org/10.1124/dmd.31.8.973
Schubert-Zsilavecz, Manfred
- You have accessDEGRADATION OF GINSENOSIDES IN HUMANS AFTER ORAL ADMINISTRATIONMona Abdel Tawab, Ute Bahr, Michael Karas, Mario Wurglics and Manfred Schubert-ZsilaveczDrug Metabolism and Disposition August 2003, 31 (8) 1065-1071; DOI: https://doi.org/10.1124/dmd.31.8.1065
Shimada, Tsutomu
- You have accessROLES OF HUMAN CYP2A6 AND 2B6 AND RAT CYP2C11 AND 2B1 IN THE 10-HYDROXYLATION OF (–)-VERBENONE BY LIVER MICROSOMESMitsuo Miyazawa, Atsushi Sugie and Tsutomu ShimadaDrug Metabolism and Disposition August 2003, 31 (8) 1049-1053; DOI: https://doi.org/10.1124/dmd.31.8.1049
Sprague, Christopher L.
- You have accessDETECTION OF CARBOXYLIC ACIDS AND INHIBITION OF HIPPURIC ACID FORMATION IN RATS TREATED WITH 3-BUTENE-1,2-DIOL, A MAJOR METABOLITE OF 1,3-BUTADIENEChristopher L. Sprague and Adnan A. ElfarraDrug Metabolism and Disposition August 2003, 31 (8) 986-992; DOI: https://doi.org/10.1124/dmd.31.8.986
Springer, Dietmar
- You have accessIDENTIFICATION OF CYTOCHROME P450 ENZYMES INVOLVED IN THE METABOLISM OF 4′-METHYL-α-PYRROLIDINOPROPIOPHENONE, A NOVEL SCHEDULED DESIGNER DRUG, IN HUMAN LIVER MICROSOMESDietmar Springer, Liane D. Paul, Roland F. Staack, Thomas Kraemer and Hans H. MaurerDrug Metabolism and Disposition August 2003, 31 (8) 979-982; DOI: https://doi.org/10.1124/dmd.31.8.979
Staack, Roland F.
- You have accessIDENTIFICATION OF CYTOCHROME P450 ENZYMES INVOLVED IN THE METABOLISM OF 4′-METHYL-α-PYRROLIDINOPROPIOPHENONE, A NOVEL SCHEDULED DESIGNER DRUG, IN HUMAN LIVER MICROSOMESDietmar Springer, Liane D. Paul, Roland F. Staack, Thomas Kraemer and Hans H. MaurerDrug Metabolism and Disposition August 2003, 31 (8) 979-982; DOI: https://doi.org/10.1124/dmd.31.8.979
Stahl, Frank
- You have accessCOMPARISON OF PRIMARY HUMAN HEPATOCYTES AND HEPATOMA CELL LINE HEPG2 WITH REGARD TO THEIR BIOTRANSFORMATION PROPERTIESStefan Wilkening, Frank Stahl and Augustinus BaderDrug Metabolism and Disposition August 2003, 31 (8) 1035-1042; DOI: https://doi.org/10.1124/dmd.31.8.1035
Sugie, Atsushi
- You have accessROLES OF HUMAN CYP2A6 AND 2B6 AND RAT CYP2C11 AND 2B1 IN THE 10-HYDROXYLATION OF (–)-VERBENONE BY LIVER MICROSOMESMitsuo Miyazawa, Atsushi Sugie and Tsutomu ShimadaDrug Metabolism and Disposition August 2003, 31 (8) 1049-1053; DOI: https://doi.org/10.1124/dmd.31.8.1049
T
Tawab, Mona Abdel
- You have accessDEGRADATION OF GINSENOSIDES IN HUMANS AFTER ORAL ADMINISTRATIONMona Abdel Tawab, Ute Bahr, Michael Karas, Mario Wurglics and Manfred Schubert-ZsilaveczDrug Metabolism and Disposition August 2003, 31 (8) 1065-1071; DOI: https://doi.org/10.1124/dmd.31.8.1065
Trager, William F.
- You have accessKIIV, AN IN VIVO PARAMETER FOR PREDICTING THE MAGNITUDE OF A DRUG INTERACTION ARISING FROM COMPETITIVE ENZYME INHIBITIONJohn M. Neal, Kent L. Kunze, René H. Levy, Robert A. O'Reilly and William F. TragerDrug Metabolism and Disposition August 2003, 31 (8) 1043-1048; DOI: https://doi.org/10.1124/dmd.31.8.1043
Tschirret-Guth, Richard A.
- You have accessSUBSTITUENT EFFECT ON THE REDUCTIVE N-DEARYLATION OF 3-(INDOL-1-YL)-1,2-BENZISOXAZOLES BY RAT LIVER MICROSOMESRichard A. Tschirret-Guth and Harold B. WoodDrug Metabolism and Disposition August 2003, 31 (8) 999-1004; DOI: https://doi.org/10.1124/dmd.31.8.999
V
Vaz, Alfin D. N.
- You have accessIN VITRO DRUG INTERACTIONS OF CYTOCHROME P450: AN EVALUATION OF FLUOROGENIC TO CONVENTIONAL SUBSTRATESLawrence H. Cohen, Michael J. Remley, David Raunig and Alfin D. N. VazDrug Metabolism and Disposition August 2003, 31 (8) 1005-1015; DOI: https://doi.org/10.1124/dmd.31.8.1005
W
West, David B.
- You have accessA TRANSGENIC MOUSE MODEL WITH A LUCIFERASE REPORTER FOR STUDYING IN VIVO TRANSCRIPTIONAL REGULATION OF THE HUMAN CYP3A4 GENEWeisheng Zhang, Anthony F. Purchio, Kevin Chen, Jianming Wu, Li Lu, Richard Coffee, Pamela R. Contag and David B. WestDrug Metabolism and Disposition August 2003, 31 (8) 1054-1064; DOI: https://doi.org/10.1124/dmd.31.8.1054
Wilkening, Stefan
- You have accessCOMPARISON OF PRIMARY HUMAN HEPATOCYTES AND HEPATOMA CELL LINE HEPG2 WITH REGARD TO THEIR BIOTRANSFORMATION PROPERTIESStefan Wilkening, Frank Stahl and Augustinus BaderDrug Metabolism and Disposition August 2003, 31 (8) 1035-1042; DOI: https://doi.org/10.1124/dmd.31.8.1035
Wood, Harold B.
- You have accessSUBSTITUENT EFFECT ON THE REDUCTIVE N-DEARYLATION OF 3-(INDOL-1-YL)-1,2-BENZISOXAZOLES BY RAT LIVER MICROSOMESRichard A. Tschirret-Guth and Harold B. WoodDrug Metabolism and Disposition August 2003, 31 (8) 999-1004; DOI: https://doi.org/10.1124/dmd.31.8.999
Wu, Jianming
- You have accessA TRANSGENIC MOUSE MODEL WITH A LUCIFERASE REPORTER FOR STUDYING IN VIVO TRANSCRIPTIONAL REGULATION OF THE HUMAN CYP3A4 GENEWeisheng Zhang, Anthony F. Purchio, Kevin Chen, Jianming Wu, Li Lu, Richard Coffee, Pamela R. Contag and David B. WestDrug Metabolism and Disposition August 2003, 31 (8) 1054-1064; DOI: https://doi.org/10.1124/dmd.31.8.1054
Wurglics, Mario
- You have accessDEGRADATION OF GINSENOSIDES IN HUMANS AFTER ORAL ADMINISTRATIONMona Abdel Tawab, Ute Bahr, Michael Karas, Mario Wurglics and Manfred Schubert-ZsilaveczDrug Metabolism and Disposition August 2003, 31 (8) 1065-1071; DOI: https://doi.org/10.1124/dmd.31.8.1065
Y
Yao, Xinsheng
- You have accessIDENTIFICATION OF A RARE SULFONIC ACID METABOLITE OF ANDROGRAPHOLIDE IN RATSXiangjiu He, Jiankuan Li, Hao Gao, Feng Qiu, Ke Hu, Xiangmin Cui and Xinsheng YaoDrug Metabolism and Disposition August 2003, 31 (8) 983-985; DOI: https://doi.org/10.1124/dmd.31.8.983
Yokota, Hiroshi
- You have accessGLUCURONIDATION AND EXCRETION OF NONYLPHENOL IN PERFUSED RAT LIVERTomo Daidoji, Hiroki Inoue, Seiyu Kato and Hiroshi YokotaDrug Metabolism and Disposition August 2003, 31 (8) 993-998; DOI: https://doi.org/10.1124/dmd.31.8.993
Z
Zhang, Dawei
- You have accessMOLECULAR CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF RAT MULTIDRUG RESISTANCE PROTEIN 1 (MRP1)Kenichi Nunoya, Caroline E. Grant, Dawei Zhang, Susan P. C. Cole and Roger G. DeeleyDrug Metabolism and Disposition August 2003, 31 (8) 1016-1026; DOI: https://doi.org/10.1124/dmd.31.8.1016
Zhang, Weisheng
- You have accessA TRANSGENIC MOUSE MODEL WITH A LUCIFERASE REPORTER FOR STUDYING IN VIVO TRANSCRIPTIONAL REGULATION OF THE HUMAN CYP3A4 GENEWeisheng Zhang, Anthony F. Purchio, Kevin Chen, Jianming Wu, Li Lu, Richard Coffee, Pamela R. Contag and David B. WestDrug Metabolism and Disposition August 2003, 31 (8) 1054-1064; DOI: https://doi.org/10.1124/dmd.31.8.1054
Zhou, Shufeng
- You have accessCYP1A1-MEDIATED ACTIVATION OF THALIDOMIDE AND SUPPRESSION OF EMBRYO FIBROBLAST PROLIFERATIONShufeng ZhouDrug Metabolism and Disposition August 2003, 31 (8) 1072; DOI: https://doi.org/10.1124/dmd.31.8.1072